Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chuang, Sung Ting ^a   Kuo, Yueh Hsiung ^b,c   Su, Ming Jai ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID DERIVATIVE; COLLAGEN; FIBRONECTIN; FIZZY RELATED PROTEIN; FZR1 PROTEIN, MOUSE; KS370G; PROTEASE NEXIN I; SERPINE2 PROTEIN, MOUSE; SMAD2 PROTEIN; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN; SMAD3 PROTEIN, MOUSE; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL; CELL LINE; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROSIS; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; ISCHEMIA; KIDNEY DISEASES; KIDNEY TUBULE; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; REPERFUSION INJURY; VASCULARIZATION;

ANIMALS; CAFFEIC ACIDS; CDH1 PROTEINS; CELL LINE; COLLAGEN; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; FIBROSIS; HUMANS; ISCHEMIA; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MICE, INBRED ICR; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPERFUSION INJURY; SERPIN E2; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 84904795863     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05814     Document Type: Article

References (38)

1. Zhou, D., Tan, R., Zhou, L., Li, Y. & Liu, Y. Kidney tubular b-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep 3, 1878 (2013
2. Li, Y. et al. Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition. PloS one 8, e66356 (2013
3. Yang, Y. S. et al. Polyphenols of Hibiscus sabdariffa improved diabetic nephropathy via attenuating renal epithelial mesenchymal transition. J Agric Food Chem 61, 7545-7551 (2013
4. Liu, Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21, 212-222 (2010
5. Erdogan, H., Fadillioglu, E., Yagmurca, M., Ucar, M. & Irmak, M. K. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 34, 41-46 (2006 (Pubitemid 43234713)
6. Hung, T. J. et al. 20-Hydroxyecdysone attenuates TGF-beta1-induced renal cellular fibrosis in proximal tubule cells. J Diabetes Complications 26, 463-469 (2012
7. Chen, H. Y. et al. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 60, 590-601 (2011
8. Manotham, K. et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 65, 871-880 (2004 (Pubitemid 38251062)
9. Lopez-Hernandez, F. J. & Lopez-Novoa, J. M. Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347, 141-154 (2012
10. Zhou, T. B., Qin, Y. H., Lei, F. Y., Huang, W. F. & Drummen, G. P. Prohibitin attenuates oxidative stress and extracellular matrix accumulation in renal interstitial fibrosis disease. PloS one 8, e77187 (2013
11. Chen, S., Jim, B. & Ziyadeh, F. N. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23, 532-543 (2003 (Pubitemid 38030087)
12. Verrecchia, F. & Mauviel, A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118, 211-215 (2002 (Pubitemid 34158472)
13. Klahr, S. &Morrissey, J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283, F861-F875 (2002 (Pubitemid 35192452)
14. Chevalier, R. L., Forbes, M. S. &Thornhill, B. A. Ureteral obstruction as amodel of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75, 1145-1152 (2009
15. Krag, S., Danielsen, C. C., Carmeliet, P., Nyengaard, J. & Wogensen, L. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease. Kidney Int 68, 2651-2666 (2005 (Pubitemid 43251011)
16. Jung, G. S. et al. Clusterin attenuates the development of renal fibrosis. J Am Soc Nephrol 23, 73-85 (2012
17. Binder, B. R. et al. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17, 56-61 (2002
18. Matsuo, S. et al. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int 67, 2221-2238 (2005 (Pubitemid 41623383)
19. Chen, K. H. et al. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-beta/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem Biol Interact 190, 45-53 (2011
20. Rah, D. K. et al. Protection of rabbit kidney from ischemia/reperfusion injury by green tea polyphenol pretreatment. Arch Pharm Res 30, 1447-1454 (2007
21. Giovannini, L. et al. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 37, 262-270 (2001 (Pubitemid 32193504)
22. Lu, D. Y. et al. Anti-neuroinflammatory effect of a novel caffeamide derivative, KS370G, in microglial cells. Mol Neurobiol 48, 863-874 (2013
23. Weng, Y. C. et al. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart. Eur J Pharmacol 684, 108-115 (2012
24. Weng, Y. C. et al. Caffeic Acid Phenylethyl Amide Protects against theMetabolic Consequences in Diabetes Mellitus Induced by Diet and Streptozocin. Evid Based Complement Alternat Med 2012, 984780 (2012
25. Chiang, C. K. et al. Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro. Br J Pharmacol 163, 586-597 (2011
26. Derynck, R., Zhang, Y. & Feng, X. H. Smads: transcriptional activators of TGFbeta responses. Cell 98, 737-740 (1998 (Pubitemid 29014453)
27. Hwang, M. et al. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 81, 48-54 (2006 (Pubitemid 43946855)
28. Jung, K. J., Kim, J., Park, Y. K., Yoon, Y. R. & Park, K. M. Wen-pi-tang-Hab-Wuling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling. Food Chem Toxicol 48, 522-529 (2010
29. Zeng, J., Dou, Y., Guo, J., Wu, X. & Dai, Y. Paeoniflorin of Paeonia lactiflora prevents renal interstitial fibrosis induced by unilateral ureteral obstruction in mice. Phytomedicine 20, 753-759 (2013
30. Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110, 341-350 (2002 (Pubitemid 34847966)
31. Neilson, E. G.Mechanisms of disease: Fibroblasts-A new look at an old problem. Nat Clin Pract Nephrol 2, 101-108 (2006 (Pubitemid 43355218)
32. Fogo, A. B. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 7, 147-159 (1999 (Pubitemid 29210177)
33. Hills, C. E. & Squires, P. E. TGF-beta1-induced epithelial-to- mesenchymal transition and therapeutic intervention in diabetic nephropathy.AmJNephrol 31, 68-74 (2010
34. Cheng, J.&Grande, J. P. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) 227, 943-956 (2002 (Pubitemid 36008302)
35. Eddy, A. A. Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost 101, 656-664 (2009
36. Oda, T. et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60, 587-596 (2001 (Pubitemid 32678902)
37. Ha,H., Oh, E. Y.&Lee, H. B. The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nat Rev Nephrol 5, 203-211 (2009
38. Samarakoon, R., Overstreet, J. M., Higgins, S. P. & Higgins, P. J. TGF-beta1-. SMAD/p53/USF2-.PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res 347, 117-128 (2012).